US mealworm regulation: no pre-market approval, no novel food framework

The US regulatory model: general food law, not novel food

The United States approaches insect-based foods fundamentally differently from the EU. There is no pre-market safety assessment. There is no novel food application. There is no species-by-species authorisation list.

Instead, insects intended for human consumption are treated as conventional food under the Federal Food, Drug, and Cosmetic Act. The FDA’s position is straightforward: insects are food if they are produced, packaged, and labelled in compliance with general food safety requirements. The agency does not pre-approve, but it can take enforcement action post-market if a product is adulterated or misbranded.

This makes the US the easiest major market to enter from a regulatory standpoint. A mealworm producer who meets GMP standards, maintains sanitary production conditions, and labels products correctly can sell into the US market without any novel food application. There is no equivalent of the EFSA safety dossier, the EU five-year exclusivity period, or the UK FSA transitional arrangement.

FDA and AAFCO: parallel paths for human food and pet food

For human food, the FDA applies its standard food safety framework:

• Products must be clean, wholesome, and produced under sanitary conditions
• Facilities must register with the FDA and comply with Preventive Controls for Human Food (21 CFR Part 117)
• Labelling must comply with FDA requirements (identity, net quantity, ingredients, allergen declarations, nutrition facts)
• No specific GRAS (Generally Recognized As Safe) notice for T. molitor has been identified in the FDA inventory — but GRAS is not required for market access under this framework

For pet food, the Association of American Feed Control Officials (AAFCO) has explicitly approved mealworm protein for use in dog food. This is a significant regulatory milestone: AAFCO’s ingredient definitions are adopted by most US states, creating a clear pathway for insect-based pet food products. Expansion to other pet food categories (cat food, treats) is likely but not yet formalised.

For animal feed, the FDA’s Center for Veterinary Medicine applies the same general safety framework. There is no EU-style list of approved insect species for feed — producers operate under general feed safety requirements.

What this means for a producer

The practical implications are significant:

1. Speed to market. A US market entry can happen in months rather than the 2–5 years a novel food application requires in the EU or UK. There is no waiting for an assessment, no dossier preparation, and no exclusivity period that blocks competitors.

2. Self-certification burden. The absence of pre-market oversight means the producer carries the compliance burden. You must demonstrate — and document — that your product is safe, sanitary, and properly labelled. If the FDA challenges your product post-market, you need evidence. The EU’s dossier system front-loads this; the US back-loads it.

3. State-level variation. Food labelling and some safety requirements vary by state. Producers selling nationwide should be aware of California’s Proposition 65 requirements, state-level food codes, and any state-specific allergen labelling rules.

4. No exclusivity. Unlike the EU’s five-year data protection for novel food applicants (e.g., NutriÉarth’s UV-treated powder exclusivity until 2030), the US provides no market exclusivity for food ingredients. Any producer meeting the standards can sell.

Allergy and labelling considerations

The FDA requires food allergen labelling under the Food Allergen Labeling and Consumer Protection Act (FALCPA). Insects are not currently listed as a “major food allergen” (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans are). However:

• Cross-reactivity with crustaceans (shrimp, crab, lobster) is documented and flagged by EFSA. US producers should consider voluntary allergen labelling warning consumers with shellfish allergies.
• The FDA can require allergen labelling if evidence of a public health risk emerges.
• Feed-through allergens (e.g., gluten from wheat-based substrate) should be declared if present in the final product.

The frass situation

The US has no insect-specific frass or fertiliser framework. Insect manure falls under general fertiliser regulations at federal (EPA) and state levels. Producers selling frass as a fertiliser or soil amendment must navigate state-by-state registration requirements, which vary considerably. This is a regulatory gap — and a practical burden for US mealworm farmers who want to monetise frass as a revenue stream.

Comparison with other jurisdictions

Aspect	US	EU	UK	Canada
Pre-market approval	No	Yes (EFSA)	Yes (FSA)	No (non-novel)
Novel food application	Not required	Required	Required	Exempt
Timeline to market	Months	2–5 years	Unknown (pending)	Immediate
Exclusivity	No	Yes (5 years, applicant-specific)	N/A	No
Pet food pathway	AAFCO (dog food)	Approved	Approved	Permitted
Frass framework	No	Yes (processed manure)	Consultation	No

Bottom line

The US is the fastest market to enter and carries the lowest regulatory barrier of any major economy. The trade-off is that you carry more self-certification burden and have fewer explicit government approvals to show buyers. For an SMB producer, the absence of the novel food application process is a genuine competitive advantage — provided you invest in the GMP, documentation, and labelling rigour the system expects.

This is also why the US model is unlikely to be replicated by countries actively building insect regulatory frameworks. Most nations are following the EU novel food model because it provides pre-market safety assurance that their consumers and trade partners expect.